Now Approved:

EPIDIOLEX® (cannabidiol) oral solution is indicated for the treatment of seizures associated with
Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older.

To learn more, including important safety information and access to the full prescribing information, visit Epidiolex.com.